Report overview
In biological system, it means to calculate the whole number by marking part of individuals.
This report aims to provide a comprehensive presentation of the global market for Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarkers. This report contains market size and forecasts of Biomarkers in global, including the following market information:
Global Biomarkers Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Biomarkers market was valued at US$ 64760 million in 2022 and is projected to reach US$ 161780 million by 2029, at a CAGR of 14.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest consumption place, with a consumption market share nearly 32% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 22.5%.
We surveyed the Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biomarkers Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Biomarkers Market Segment Percentages, by Type, 2022 (%)
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Other
Global Biomarkers Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Biomarkers Market Segment Percentages, by Application, 2022 (%)
Diagnostics
Drug Discovery
Personalized Medicine
Other
Global Biomarkers Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Biomarkers Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biomarkers revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Biomarkers revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biomarkers, market overview.
Chapter 2: Global Biomarkers market size in revenue.
Chapter 3: Detailed analysis of Biomarkers company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
